Weifeng Liu

Sestrin 2 and sestrin 3 suppress NK-92 cell-mediated cytotoxic activity on ovarian cancer cells through AMPK and mTORC 1 signaling

Deyi Zhuang, Jingfang Chen, Xuejin Wang, 2017 .

Reduction-responsive nucleic acid nanocarrier-mediated miR-22 inhibition of PI3K/AKT pathway for the treatment of patient-derived tumor xenograft osteosarcoma

Meizhou Sun, S. Duan, Bingran Yu, 2023, Bioactive Materials.

Kinome-wide CRISPR-Cas9 knockout screens revealed PLK1 as a therapeutic target for osteosarcoma

Dafu Chen, Renxian Wang, Jianxun Guo, 2023, Cell death discovery.

Piezo-enhanced near infrared photocatalytic nanoheterojunction integrated injectable biopolymer hydrogel for anti-osteosarcoma and osteogenesis combination therapy

Changhao Li, Cairong Xiao, Renxian Wang, 2024, Bioactive materials.

Enhanced pyroptosis induction with pore-forming gene delivery for osteosarcoma microenvironment reshaping

Renxian Wang, Jianping Mao, Jingjing Cao, 2024, Bioactive materials.

Sestrin2 and sestrin3 suppress NK-92 cell-mediated cytotoxic activity on ovarian cancer cells through AMPK and mTORC1 signaling

Xuejin Wang, Weifeng Liu, Shaoxian Hong, 2017, Oncotarget.